NAFDAC strengthens regulatory oversight of blood products in Nigeria

NAFDAC has strengthened oversight of blood and blood products in Nigeria, classifying them as essential medicines requiring consistent availability and assured quality, safety, and affordability. The development relates to healthcare-sector regulation but does not identify a specific listed company or direct corporate action.